Cordella Pulmonary Artery Sensor System (CorPASS)
Endotronix, Inc. · Decision date Oct 22, 2025
What did the FDA decide?
FDA records P230040/S023 as a supplement to PMA P230040, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Oct 22, 2025.
FDA approval order statement
implementation of a semi-automated inspection process
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 22, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P230040/S023
- Regulatory pathway
- PMA supplement
- Applicant
- Endotronix, Inc.
- Product code
- MOM
- Decision code
- OK30
- Decision date
- Oct 22, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, hemodynamic, implantable.
- Applicant
- Endotronix, Inc.
- Product code
- MOM
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P230040. Subsequent supplements may change the device or its indications.
FDA decision timeline
P230040 · Original PMA
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S017 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S018 · Related supplement
CorPASS System
P230040/S019 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S023 received
Application receipt date recorded by FDA.
P230040/S021 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S020 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S022 · Related supplement
CorPASS System
P230040/S023 · FDA decision
30-Day Notice
P230040/S024 · Related supplement
CorPASS System
P230040/S015 · Related supplement
CorPASS System
P230040/S025 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S026 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S027 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S028 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S029 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S032 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S033 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S034 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S031 · Related supplement
Cordelia Pulmonary Artery Pressure Sensor System (CorPASS)
P230040/S035 · Related supplement
Cordella Pulmonary Artery Sensor System (CorPASS)
P230040/S030 · Related supplement
Cordella Pulmonary Artery Sensor System
Timeline entries are records held by MedtechLedger for P230040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P230040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Endotronix, Inc. | PMA approval | Jun 20, 2024 | FDA | |
| Endotronix, Inc. | PMA supplement | Aug 14, 2025 | FDA | |
CorPASS SystemP230040/S018 | Endotronix, Inc. | PMA supplement | Aug 26, 2025 | FDA |
| Endotronix, Inc. | PMA supplement | Sep 10, 2025 | FDA | |
| Endotronix, Inc. | PMA supplement | Sep 29, 2025 | FDA | |
| Endotronix, Inc. | PMA supplement | Sep 30, 2025 | FDA | |
CorPASS SystemP230040/S022 | Endotronix, Inc. | PMA supplement | Oct 6, 2025 | FDA |
CorPASS SystemP230040/S024 | Endotronix, Inc. | PMA supplement | Nov 25, 2025 | FDA |
CorPASS SystemP230040/S015 | Endotronix, Inc. | PMA supplement | Dec 19, 2025 | FDA |
| Endotronix, Inc. | PMA supplement | Jan 9, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Feb 13, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Feb 17, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Feb 24, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Mar 2, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Aug 13, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Sep 25, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 14, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Endotronix, Inc. | PMA supplement | Oct 20, 2026 | FDA | |
Cordella Pulmonary Artery Sensor SystemP230040/S030 | Endotronix, Inc. | PMA supplement | Oct 29, 2026 | FDA |
Explore the linked device profile
Other records with product code MOM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA | |
CardioMEMS PA Sensor and Delivery SystemP100045/S093 | ABBOTT MEDICAL | PMA supplement | Sep 30, 2026 | FDA |
| ABBOTT MEDICAL | PMA supplement | Sep 11, 2026 | FDA | |
CardioMEMS HF SystemP100045/S090 | ABBOTT MEDICAL | PMA supplement | Jun 1, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Endotronix, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 1415 W. Diehl Rd., Suite 500w, Naperville, IL, 60563
Sources and methodology
- Original FDA record: P230040/S023
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






